Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits
To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...
DexCom (DXCM) Fell Due to Growth Deceleration
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...
Down More Than 50% From Its High, Is DexCom Stock a Buy?
The healthcare stock is in a tailspin, trading down more than 50% from its high after a steep sell-off following its latest ...
Hosted on MSN6d
Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's like
Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.
Mena FN2d
Continuous Glucose Monitoring Devices Market Projected To Witness Substantial Growth, 2024-2031: Medtronic, Dexcom, Inc.
Continuous Glucose Monitoring Devices Market to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9% between 2024 and 2031 BURLINGAME, CA, UNITED STATES, October 15, 2024 /EINPresswire / -- A ...
This Is What Whales Are Betting On DexCom
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...
Abbott bumps up profit forecast on strong medical device sales
Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...
Invest Lithuania7d
Dexcom Expands Operations in Lithuania with New Clinical Affairs Team
Lithuania has proven to be an excellent fit for Dexcom due to its strong business environment, skilled workforce, and ...
DXCM INVESTOR UPDATE: BFA Law Notifies DexCom, Inc. Investors to Contact the Firm Before October 21 Deadline in Securities Fraud Class Action Lawsuit
New York, New York-- (Newsfile Corp. - October 12, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and ...
Jim Cramer Reports That DexCom, Inc. (DXCM) Is ‘Down Roughly 41%’
We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...
Investing10d
Canaccord reiterates stock target, buy rating on DexCom after analyst trial
The firm's analyst shared insights from a personal trial of continuous glucose monitoring (CGM) devices, including DexCom's Stelo and Abbott's Lingo, as well as Abbott's prescription-only Libre 3 ...